Literature DB >> 12177375

Nonmotor fluctuations in Parkinson's disease: frequent and disabling.

Tatiana Witjas1, E Kaphan, J P Azulay, O Blin, M Ceccaldi, J Pouget, M Poncet, A Ali Chérif.   

Abstract

OBJECTIVE: To assess the frequency and disability caused by nonmotor fluctuations (NMF) in PD.
METHODS: A structured questionnaire was administered to 50 patients with PD with motor fluctuations (MF), focused on 54 nonmotor symptoms classified in three subgroups: 26 dysautonomic, 21 cognitive and psychiatric, and seven pain/sensory NMF. The link between each NMF and the motor state was determined. Patients were asked to grade their disability from 0 (no disability) to 4 (maximum discomfort) and to specify which kind of fluctuation subgroup (motor or nonmotor) was the most incapacitating. A statistical analysis was performed to determine the frequency of each NMF and to determine whether the level of disability resulting from NMF could be correlated to the main characteristics of the population.
RESULTS: All patients had had at least one type of NMF, most of which were associated with the "off" state. Anxiety (66%), drenching sweats (64%), slowness of thinking (58%), fatigue (56%), and akathisia (54%) were the most frequent NMF. Some symptoms such as anxiety or dyspnea correlated with a greater level of disability. The total number of NMF was found to be correlated with the motor disability. Incapacity resulting from the dysautonomic fluctuations was also significantly correlated with levodopa treatment. Surprisingly, 28% of the patients stated that NMF involved a greater degree of disability than MF.
CONCLUSION: Nonmotor fluctuations are frequent and debilitating in PD.

Entities:  

Mesh:

Year:  2002        PMID: 12177375     DOI: 10.1212/wnl.59.3.408

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  136 in total

1.  Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue.

Authors:  Hong-Bo Wen; Zhen-Xin Zhang; Han Wang; Ling Li; Honglei Chen; Yiming Liu; Baorong Zhang; Qun Xu
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

Review 3.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

4.  Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease.

Authors:  Giovanni Abbruzzese; Angelo Antonini; Paolo Barone; Fabrizio Stocchi; Tiziano Tamburini; Laura Bernardi; Marianna Amboni; Laura Vacca; Valeria Posocco; Delia Colombo
Journal:  Neurol Sci       Date:  2012-02-04       Impact factor: 3.307

Review 5.  Continuous drug delivery in Parkinson's disease.

Authors:  Marina Senek; Dag Nyholm
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 6.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Tolcapone addition improves Parkinson's disease associated nonmotor symptoms.

Authors:  Thomas Müller
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 8.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

9.  Effect of visual cues on the resolution of perceptual ambiguity in Parkinson's disease and normal aging.

Authors:  Mirella Díaz-Santos; Bo Cao; Samantha A Mauro; Arash Yazdanbakhsh; Sandy Neargarder; Alice Cronin-Golomb
Journal:  J Int Neuropsychol Soc       Date:  2015-03-13       Impact factor: 2.892

10.  Perceptions of effort during handgrip and tongue elevation in Parkinson's disease.

Authors:  Nancy Pearl Solomon; Donald A Robin
Journal:  Parkinsonism Relat Disord       Date:  2005-09       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.